These medications include semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro, Zepbound)which is actually a dual GIP/GLP-1 receptor agonistdulaglutide (Trulicity), and liraglutide (Victoza, Saxenda)
Methods We have summarized the wide range of completed and ongoing mechanistic studies in relation to the pathways under investigation, the different investigative approaches utilized, and the variety of populations targeted (Figures 1 and 2)
Compounding changes where the preparation comes from, not the level of medical supervision the treatment needs
As we navigate through the complexities of peptide therapy, we will also highlight the importance of consulting healthcare professionals for personalized guidance
The notation matters because NAD+ and NADH are functionally opposite
PCSK9 as a therapeutic target for cardiovascular disease